| Value |
Category |
| 5-10% has history of blood pressure started on HCTZ 25mg OD |
|
| 5-10% - RISK PREDICTION |
|
| 5-10%- LOW RISK PREDICTION |
|
| <5% RISK PREDICTION |
|
| > 30% |
|
| >10-20% stage I |
|
| >30% RISK PREDICTION |
|
| ADVICE TO VISIT THE KARIOBANGI CLINIC |
|
| ADVICED ON CUTTING DOWN WEIGHT |
|
| ADVICED ON LIFESTYLE CHANGE RISK PREDICTION >10-20% |
|
| ADVICED ON LIFESTYLE MODIFICATION |
|
| ADVICED ON WEIGHT REDUCTION |
|
| ADVICED TO CONTINUE COLLECTING INSULIN AT KARIOBANGI |
|
| AGE 62 YRS. RISK PREDICTION >20% |
|
| AGE 63 WAS ON HCTZ CT HCTZ |
|
| AGE GREATER THAN OR EQUAL TO60 YEARS, RISK PREDICTION - MODERATE >10-20%. KNOWN ASTHMATIC. SYSTOLIC >160 |
|
| AGE NOT IN THE CHART |
|
| Advised on lifestyle change . Risk predicton moderate >10-20% |
|
| CLIENT FOLLOWED UP AT KNH FOR DM AND HYPERTENSION. SHE PREFERS TO CONTINUE TREATMENT FOR THE SAME AT KENYATTA. SHE HAS NO PROBLEM WITH TREATMENT COST. |
|
| CLIENT WENT HOME TO BRING THE PREMEDICATION DRUGS BUT THE CLINIC WAS CLOSED BEFORE HE RETURNED |
|
| COMPLAINS OF HEADACHE AND DIZZINESS |
|
| D.O.B during independence??? Risk prediction>10-20% Stage 2 HTW. |
|
| DIABETIC |
|
| Dm only: Also known asthmatic. |
|
| FASTING BLOOD SUGAR 9.2 |
|
| HAS HISTORY OF BLOOD PRESSURE. ON NIFEDIPINE 20MG, ENALAPRIL 5MG RISK PREDICTION 5-10% |
|
| HIGH >20-20% |
|
| HIGH >30% |
|
| HIGH >30% II HYPERTENSION |
|
| HIGH PREDICTION > 30% |
|
| HIGH PREDICTION >30% |
|
| HIGH PREDICTION >30% |
|
| HIGH RISK >20-20% |
|
| HIGH RISK >30% |
|
| HIGH RISK PREDICTION 20-20% |
|
| HIGH RISK PREDICTION >30% |
|
| HTN STAGE II RISK PREDICTION >20-20% |
|
| HYPER TENSION STAGE II RISK PREDICTION MODERATE >10-20% |
|
| HYPERTENSION STAGE II >10-20% |
|
| HYPERTENSION STAGE II RISK PREDICTION-MODERATE |
|
| HYPERTENSIVE STAGE II RISK PREDICTION LOW 5-10%, BEGIN MEDS |
|
| High prediction > 20-20% |
|
| High, greater than 30% |
|
| II HYPERTENSIVE |
|
| Know diabetic, measured from Hospice |
|
| LOW <5% |
|
| LOW PREDICTION 5-10% |
|
| LOW PREDICTION 5-10% |
|
| LOW PREDICTION <5% |
|
| LOW RISK <5-10% + DIABETIC |
|
| LOW RISK<5% |
|
| MODERATE >10-20% |
|
| MODERATE >10-20% |
|
| MODERATE PREDICTION >10-20% |
|
| MODERATE PREDICTION 10-20% |
|
| MODERATE PREDICTION > 10-20% |
|
| MODERATE PREDICTION >10-20% |
|
| MODERATE PREDICTION: 10-20% |
|
| MODERATE PREDITION >10-20% |
|
| MODERATE RISK PREDICTION |
|
| MODERATE RISK PREDICTION >10-20% |
|
| MODERATE>10-20% |
|
| MONITOR BLOOD GLUCOSE. FBS RECOMMENDED NEXT VISIT. RISK PREDICTION HIGH >30% |
|
| NO DRUGS |
|
| NO DRUGS ISSUED |
|
| NON SMOKER,TAKES ALCOHOL.RISK PREDICTION LOW <5%.hYPERTENSIVE STAGE II |
|
| NONE |
|
| NONE HYPERTENSIVE FOR REVIEW ON 3/11/2012. RISK PREDICTION 5-10% |
|
| No chart |
|
| No chart; |
|
| PATIENTS HAS DRUGS FOR 1/12 WAS SEEN AT ST MARYS LANGATA. RISK >20-20% BUT ON STAGE REVIEW 1/12 |
|
| REFERRED TO CONTINUE WITH KARIOBANGI CLINIC |
|
| RISK 10-20% |
|
| RISK 10-20% DIETARY CONTROL/ BEHAVIORAL CONTROL |
|
| RISK 20% |
|
| RISK 20% HAS BEEN ON ENALAPRIL |
|
| RISK 20% LIFESTYLE & HCTZ |
|
| RISK 30% ON RX |
|
| RISK 5-10% |
|
| RISK 5-10% LIFESTYLE ADJUSTMENT |
|
| RISK 5-10% PT HAS BEEN ON HTN ENALAPRIL,HCTZ |
|
| RISK 5-10% LIFESTYLE ADJUSTMENT |
|
| RISK 5-10% LOW LIFESTYLE ADJUSTMENT |
|
| RISK 5-10% ON ANTI HTN LIFESTYLE ADJUSTMENT |
|
| RISK 5-10% STAGE 1LIFESTYLE ADJUSTMENT |
|
| RISK <5% LIFESTYLE ADJUSTMENT |
|
| RISK > 10-20% PT IS ON ENALAPRIL, HCTZ AND METFOEMIN |
|
| RISK >10-20% STAGE I HTN |
|
| RISK >10-20% STAGE I |
|
| RISK >10-20% STAGE I HTN LIFESTYLE ADJUSTMENT |
|
| RISK >20% |
|
| RISK >20% DIABETIC N HTN |
|
| RISK >20-20% |
|
| RISK >30% |
|
| RISK >30% STAGE II |
|
| RISK ABOVE 30% |
|
| RISK FACTOR >10-20% |
|
| RISK FACTOR HIGH >20-30% |
|
| RISK PRDICCTION <5% |
|
| RISK PREDICION >30% |
|
| RISK PREDICTION |
|
| RISK PREDICTION 10-20% STAGE I HTN |
|
| RISK PREDICTION 10-20% STAGE II HTN |
|
| RISK PREDICTION >10-20% |
|
| RISK PREDICTION >10-20% LIFESTYLE CHANGE WITH REVIEW AFTER 3MONTH |
|
| RISK PREDICTION >10-20% MODERATE |
|
| RISK PREDICTION >20% |
|
| RISK PREDICTION >5% |
|
| RISK PREDICTION >5%. STAGE I HTN |
|
| RISK PREDICTION MODERATE >10-20% |
|
| RISK PREDICTION 5 – 10% NO DRUGS |
|
| RISK PREDICTION 5-10% STAGE I HTN LIFESTYLE ADJUSTMENT |
|
| RISK PREDICTION >10-20% |
|
| RISK PREDICTION >20% |
|
| RISK PREDICTION HIGH >20-20% HTN STAGE II |
|
| RISK PREDICTION - <5% |
|
| RISK PREDICTION - >10-20% (MODERATE) |
|
| RISK PREDICTION - LOW <5% |
|
| RISK PREDICTION - NOT POSSIBLE BECAUSE OF THE AGE 84YEARS |
|
| RISK PREDICTION ->10-20% NO DRUGS ISSUED |
|
| RISK PREDICTION 10-20% LIFESTYLE ADJUSTMENT |
|
| RISK PREDICTION 10-20% STAGE I HYPERTENSION |
|
| RISK PREDICTION 10-20% LIFESTYLE ADJUSTMENT |
|
| RISK PREDICTION 10-20%. START LIFESTYLE MODIFICATION |
|
| RISK PREDICTION 20-20% |
|
| RISK PREDICTION 5%-10% |
|
| RISK PREDICTION 5-10% |
|
| RISK PREDICTION 5-10% LIFESTYLE ADJUSTMENT |
|
| RISK PREDICTION 5-10% NO DRUGS ISSUED |
|
| RISK PREDICTION 5-10% STAGE I HTN |
|
| RISK PREDICTION 5-10% STAGE I HTN PLAN LIFESTYLE ADJUSTMENT |
|
| RISK PREDICTION 5-10% STARTED ON TREATMENT ADVICED ON LIFESTYLE CHANGE |
|
| RISK PREDICTION 5-10% CLIENT HAS NO COMPLAIN RELATED TO DM |
|
| RISK PREDICTION 5-10% STAGE HTN LIFESTYLE ADJ |
|
| RISK PREDICTION 5-10% STAGE I HTN LIFESTYLE ADJUSTMENT |
|
| RISK PREDICTION 5-10% STAGE II HTN LIFESTYLE ADJUSTMENT |
|
| RISK PREDICTION 5-10%, (HTN STAGE II) |
|
| RISK PREDICTION < 5% |
|
| RISK PREDICTION <20% |
|
| RISK PREDICTION <5 NO DRUGS ISSUED |
|
| RISK PREDICTION <5% |
|
| RISK PREDICTION <5% NO DRUGS |
|
| RISK PREDICTION <5% NO DRUGS ISSUED |
|
| RISK PREDICTION <5% NO DRUGS ISSUEID |
|
| RISK PREDICTION <5% REQUEST FIRST TO CONTINUE WITH LIFESTYLE |
|
| RISK PREDICTION <5%. HTN STAGE I |
|
| RISK PREDICTION <5%. HTN STAGE II |
|
| RISK PREDICTION > 10- 20% |
|
| RISK PREDICTION > 10-20% |
|
| RISK PREDICTION > 20% |
|
| RISK PREDICTION > 30% |
|
| RISK PREDICTION >10% -20% (MODERATE). CLIENT HAS BEEN ON LASIX. CLIENT SUFFERED STROKE 2010 DEC |
|
| RISK PREDICTION >10%-20% |
|
| RISK PREDICTION >10%-20% NO DRUGS ISSUED |
|
| RISK PREDICTION >10%-20% (MODERATE) NO DRUGS ISSUED |
|
| RISK PREDICTION >10%-20% NO DRUGS ISSUED |
|
| RISK PREDICTION >10-20% |
|
| RISK PREDICTION >10-20% NO DRUGS |
|
| RISK PREDICTION >10-20% NO DRUGS ISSUED |
|
| RISK PREDICTION >10-20% STAGE II HTN |
|
| RISK PREDICTION >10-20% STAGE II HYPERTENSION |
|
| RISK PREDICTION >10-20% ADVISED ON LIFESTYLE |
|
| RISK PREDICTION >10-20% MODERATE |
|
| RISK PREDICTION >10-20% NO DRUGS |
|
| RISK PREDICTION >10-20% NO DRUGS ISSUED |
|
| RISK PREDICTION >10-20% STAGE I HTN LIFESTYLE ADJUSTMENT |
|
| RISK PREDICTION >10-20% STAGE I HTN LIFESTYLE ADJUSTMENT |
|
| RISK PREDICTION >10-20%. HTN STAGE 2 |
|
| RISK PREDICTION >10-20%. STAGE II |
|
| RISK PREDICTION >20% |
|
| RISK PREDICTION >20% ADVICED TO COME WITH OTHER MEDICATION SHE IS TAKING DURING THE NEXT VISIT |
|
| RISK PREDICTION >20% AGE IS 70 YEARS |
|
| RISK PREDICTION >20% ENCOURAGED TO BRING THE DRUGS SHE IS ON IN NEXT VISIT OF 03/10/12 |
|
| RISK PREDICTION >20% DIABETIC |
|
| RISK PREDICTION >20% STAGE I HTN |
|
| RISK PREDICTION >20-20% |
|
| RISK PREDICTION >20-20% HTN II |
|
| RISK PREDICTION >20-20% KNOWN HYPERTENSIVE AND ON NIFEDIPINE |
|
| RISK PREDICTION >20-20%, PATIENT IS 83YEARS OLD |
|
| RISK PREDICTION >30% |
|
| RISK PREDICTION >30% PT IS ON HYPERTENSIVES |
|
| RISK PREDICTION >30% STAGE II HTN |
|
| RISK PREDICTION >30% STAGE II HYPERTENSION |
|
| RISK PREDICTION >30% HTN STAGE II |
|
| RISK PREDICTION >30% STAGE II HTN |
|
| RISK PREDICTION >30%. BEGIN MEDS AND LIFESTYLE MODIFICATION. MONITOR RBS CLOSELY |
|
| RISK PREDICTION >5% |
|
| RISK PREDICTION >5-10% |
|
| RISK PREDICTION ABOVE 30% |
|
| RISK PREDICTION ABOVE CHART ESTIMATE PLAN START HCTZ STAGE II HTN |
|
| RISK PREDICTION HIGH |
|
| RISK PREDICTION HIGH (20-30%). BEGIN MEDS + LIFESTYLE MODIFICATION, REVIEW AFTER ONE MONTH |
|
| RISK PREDICTION HIGH 20-20% |
|
| RISK PREDICTION HIGH 20-30%. STAGE I HYPERTENSION. START LIFESTYLE MODIFICATION + MEDS |
|
| RISK PREDICTION HIGH 20-30%. START MEDS + LIFESTYLE MODIFICATION. FOR FBS NEXT VISIT |
|
| RISK PREDICTION HIGH > 20% IN STAGE II HYPERTENSION |
|
| RISK PREDICTION HIGH >20% STAGE I HYPERTENSION |
|
| RISK PREDICTION HIGH >20-20% |
|
| RISK PREDICTION HIGH >20-30% |
|
| RISK PREDICTION HIGH >20-30% STAGE I HYPERTENSION |
|
| RISK PREDICTION HIGH >20-30%. START LIFESTYLE MODIFICATION + MEDS. MONITOR RBG CLOSELY IF NO CHANGE ADD METFORMIN |
|
| RISK PREDICTION HIGH >30% |
|
| RISK PREDICTION HIGH >30%. STAGE I HYPERTENSION. START MEDS |
|
| RISK PREDICTION LOW 5-10% |
|
| RISK PREDICTION LOW 5-10% |
|
| RISK PREDICTION LOW 5-10%. BEGIN LIFESTYLE MODIFICATION. REVIEW AFTER 1MONTH |
|
| RISK PREDICTION LOW 5-10%. NOT ENROLLED SHE IS BELOW 35YRS. |
|
| RISK PREDICTION LOW 5-10%. NOT ENROLLED SHE'S BELOW 35YRS |
|
| RISK PREDICTION LOW 5-10%. TO BEGIN LIFESTYLE MODIFICATION |
|
| RISK PREDICTION LOW <5% |
|
| RISK PREDICTION LOW <5%. BEGIN LIFESTYLE MODIFICATION |
|
| RISK PREDICTION LOW <5%. CT LIFESTYLE MODIFIDICATION |
|
| RISK PREDICTION LOW <5-10%,ADVICED ON LIFESTYLE MODIFICATION |
|
| RISK PREDICTION LOW<5% |
|
| RISK PREDICTION MODERATE 10-20% |
|
| RISK PREDICTION MODERATE 10-20% STAGE II HYPERTENSION |
|
| RISK PREDICTION MODERATE 10-20%. WITH ISOLATED SYSTOLIC HYPERTEENSION |
|
| RISK PREDICTION MODERATE 10-20%. CT ANTIDIABETICS |
|
| RISK PREDICTION MODERATE 10-20%. MONITOR BP CLOSELY IFNO CHANGE AFTER 3 MONTHS START MEDS. TARGET BP IN DM IS <130/80mmHg |
|
| RISK PREDICTION MODERATE 10-20%. STAGE I HYPERTENSION. |
|
| RISK PREDICTION MODERATE 10-20%. STAGE I HYPERTENSION. START LIFESTYLE MODIFICATION. |
|
| RISK PREDICTION MODERATE 10-20%. STAGE II HYPERTENSION. |
|
| RISK PREDICTION MODERATE 5-10%. START LIFESTYLE MODIFICATION |
|
| RISK PREDICTION MODERATE <10-20%. BEGIN LIFESTYLE MODIFICATION |
|
| RISK PREDICTION MODERATE >10-20% |
|
| RISK PREDICTION MODERATE >10-20% ADVICE ON LIFESTYLE ADJUSTMENT AND MONTHLY FOLLOWUP |
|
| RISK PREDICTION MODERATE >10-20%. START LIFESTYLE MODIFICATION |
|
| RISK PREDICTION MOODERATE >10_20% NO DRUGS ISSUED |
|
| RISK PREDICTION – LOW 5 -10% HYPERTENSION 2nd DEGREE TO THYROTOXICOSIS |
|
| RISK PREDICTION: MODERATE 5-10% ADVISED ON LIFESTYLE ADJUSTMENT & ADHERENCE COUNSELLING |
|
| RISK PREDICTION<5% |
|
| RISK PREDICTION>10-20% |
|
| RISK PREDICTION>20% |
|
| RISK PREDICTION>30% |
|
| RISK PREDICTION>30% STAGE II HTN |
|
| RISK PREDICTON >10-20% |
|
| RISK PREEDICTION 5-10% |
|
| RISK REDICTION >20-20% |
|
| RISK> 20% HCTZ 25mg OD*32/7 |
|
| Risk prediction >30% |
|
| Risk > 20-20% |
|
| Risk prediction |
|
| Risk prediction mod >10-20% HTM TWO. |
|
| Risk prediction - >10% -20% (MODERATE) NO DRUGS ISSUED. |
|
| Risk prediction 20-30%. |
|
| Risk prediction 5% |
|
| Risk prediction 5-10% |
|
| Risk prediction 5-10% Stage 1 hypertension |
|
| Risk prediction > 10-20% |
|
| Risk prediction > 10-20% but patient was on meds before |
|
| Risk prediction >10-20%. No drugs issued. |
|
| Risk prediction >20%, Age 80 years, Cannot stand no measurements. |
|
| Risk prediction >5% lifestyle adjustment. |
|
| Risk prediction greater than 10-20% |
|
| Risk prediction high>20-30. start meds +lifesytle modification. |
|
| Risk prediction less than 5% |
|
| Risk prediction low 25% in stage II hypertension. |
|
| Risk prediction low (5-10). start lifesytle modification. |
|
| Risk prediction low 25% |
|
| Risk prediction low 5-10% |
|
| Risk prediction low <5-10% a follow -up kariobangi; |
|
| Risk prediction low<5% stage 1 hypertension |
|
| Risk prediction not able to calculate. Due to his age and BP 140, recommend to start Rx |
|
| Risk prediction- loe 5-10% Advised on lifesytle modification. |
|
| Risk prediction. >-20%. |
|
| Risk prediction<5%(low). |
|
| Risk prediction>30%. |
|
| SATGE II HYPERTENSION |
|
| SATGE II HYPERTENSION PATIENT REPORTED TO HAVE A HEART LESION BUT ABSCONDED CLINIC AT KNH NB: HIP AND WAIST MEASURES NOT TAKEN. SHE WAS NOT ABLE TO STAND |
|
| SEVERE HYPERTENSION - HEADACHE BLURRED VISION AGE-60 YEARS |
|
| SMOKER RISK PREDICTION >30% |
|
| STAGE 2 HYPERTENSION |
|
| STAGE I HYPERTENSION RISK PREDICTION LOW 5-10% START ON NIFEDIPINE REFFERED TO KARIOBANGI FOR FOLLOW UP |
|
| STAGE I HYPERTENSION RISK PREDICTION >30% START MEDS + LIFESTYLE ADJUSTMENT |
|
| STAGE I HYPERTENSION RISK PREDICTION >30%` |
|
| STAGE II HYPERTENSION |
|
| STAGE II HYPERTENSION NB: RESPONDENT CANNOT STAND BY HIS FEET |
|
| STAGE II HYPERTENSION RISK PREDICTION HIGH 20-30% START ANTIHYPERTENSIVE + LIFESTYLE MODIFICATION |
|
| STAGE II HYPERTENSION NB: PATIENT UNABLE TO STAND |
|
| STAGE II HYPERTENSION PREVIOUSLY SUFFERED NIFEDIPINE SIDE EFFECTS EFFECTS OF OEDEMA |
|
| STAGE II HYPERTENSION RISK 20% ALLERGIC TO ENALAPRIL (DRY COUGH) |
|
| STAGE II HYPERTENSION STARTED RX ON 21/11/2012 |
|
| STAGE II HYPERTENSION TABS NIFEDIPINE 40MG START CHECK BP 171/81 |
|
| STAGE II HYPERTENSION + DIABETES |
|
| STAGE II HYPERTENSION AND DIABETIES |
|
| STAGE II HYPERTENSION PLAIN LIFESTYLE ADJUSTMENT |
|
| STAGE II HYPERTENSION SEPARATED |
|
| STAGE II HYPERTENSION. CLIENT HAS NO HTN EMERGENCY SIGNS |
|
| STAGE II HYPERTENSION. RISK PREDICTION HIGH >20% LIFESTYLE MODIFICATION + MEDS |
|
| STAGE II HYPERTENSION.CLIENT DIDNT COME WITH DRUGS SHE IS ON SHE PREFERS TO CONTINUE WITH DRUGS SHE IS ON |
|
| STAGE II HYPERTENSIVE |
|
| START MEDS. RISK PREDICTION HIGH 20-30%; BUT TARGET BP OK |
|
| She has a histroy of hypertension Continue monitoring her BP |
|
| Stage I hypertension risk prediction greater than 20% |
|
| Stage II Hypertension. |
|
| Stage II hypertension |
|
| Stage II hypertension. Risk greater than 20-26% |
|
| Start RX Risk factor high due to age and BD NB/Respodent cannot stand. |
|
| To a Kariobangi clinic. |
|
| To be seen on 5th/4 for fashing blood sugar. |
|
| bp was too high could not be measured by BP machine |
|
| continue follow -up kARIOBANGI |
|
| hypertensive stage II risk prediction - moderate greater than 10-20% |
|
| low 5-10% |
|
| low less than 5% advised on lifestyle advised on change F/P method visit FP clinic |
|
| low prediction 5-10% |
|
| moderase >10-20% |
|
| moderate prediction 10-20% |
|
| moderate risk greater than 10-20% |
|
| moderate risk prediction |
|
| on follow-up at Kariobangi, to continue. |
|
| risk 10-20% lifestyle |
|
| risk 10-20% lifestyle adjustment |
|
| risk 20% |
|
| risk 20% lifestyle and HCTZ |
|
| risk 30% |
|
| risk 5-10% |
|
| risk 5-10% lifestyle adjustment |
|
| risk predcition > 30% |
|
| risk predcition less than 5% |
|
| risk predcition less than 5% no drugs issued |
|
| risk prediction (no chart) RBG reads high |
|
| risk prediction - moderate, greater than 10-20% |
|
| risk prediction - moderate,> 10-20% advised on lifestyle modification |
|
| risk prediction 10-20% |
|
| risk prediction 10-20% stage II HTN lifestyle |
|
| risk prediction 20-20% |
|
| risk prediction 5-10% |
|
| risk prediction 5-10% HTN Stage II |
|
| risk prediction 5-10% no drugs |
|
| risk prediction 5-10% no drugs issued |
|
| risk prediction 5-10% STG I HTN |
|
| risk prediction 5-10% low |
|
| risk prediction <5% |
|
| risk prediction > 10-20% |
|
| risk prediction > 20% |
|
| risk prediction >10-20% |
|
| risk prediction >20-20% |
|
| risk prediction >20-20% hypertension stage II |
|
| risk prediction >30% |
|
| risk prediction >30% hypertension stage II |
|
| risk prediction >30% patient is 75years old |
|
| risk prediction >5% stage I HTN |
|
| risk prediction >5-10% |
|
| risk prediction greater than 10-20% |
|
| risk prediction greater than 20% |
|
| risk prediction greater than 20-20% |
|
| risk prediction greater then 20-20% low BMI |
|
| risk prediction high 20-30% continue all meds |
|
| risk prediction high > 30% |
|
| risk prediction high > 30% Advised on lifestyle modification, meanwhile to start oral hypoglycaemics |
|
| risk prediction high >30% |
|
| risk prediction less than 5% |
|
| risk prediction low 5-10% |
|
| risk prediction low 5-10% stage II hypertension |
|
| risk prediction low < 5% |
|
| risk prediction low <5% |
|
| risk prediction low <5% hypertension stage II |
|
| risk prediction low <5% stage II hypertension |
|
| risk prediction moderate 10-20% |
|
| risk prediction moderate 20-20% |
|
| risk prediction moderate 20-30% stage I hypertension |
|
| risk prediction moderate >10%-20% |
|
| risk prediction- low: >5% |
|
| risk prediction-low 5-10%. |
|
| risk predictions 5-10% |
|
| riskprediction >10-20% |
|
| stage II HYPERTENSION |
|
| stage II hyoertension |
|
| stage II hypertension |
|
| stage II hypertension. risk prediction low 5% |
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
